Tag: Zydus Cadilla
Bharat Biotech’s partner seeks Covaxin nod in US for children between...
Covaxin, developed in India by Bharat Biotech, gained emergency approval from the World Health Organization (WHO) and has already been cleared for use in 17 countries......................
Zydus Cadila’s net profit up by 41% in Q3 FY21
While the company's consolidated revenues for the quarter at Rs. 3,796 Crore, up 4% Y-o-Y, the consolidated net sales for the quarter at Rs 3754 crore up by 6% Y-o-Y....................
Zydus gets DCGI nod for Saroglitazar Mg for the treatment of...
It becomes the first medicine for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD), a spectrum ranging from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH), which has the propensity to progress to liver cirrhosis....................
Zydus seeks approval to commence Phase III clinical trials of its...
New Delhi: Zydus Cadila has announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe, well tolerated and immunogenic in...
PM Modi visits India’s top private vaccine manufacturing facilities
On 28th November, Prime Minister of India, Narendra Modi undertook a three-city tour to the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad, and Serum Institute of India in Pune......................